Connect with us

Business

Can My Pet Use My Medical Marijuana or CBD?

Published

on

My pet is like my child, is it ok to share my medicine with them, but just in smaller doses?

In the history of medicine, men of have been the key factor and up until the 1980s women and kids were just seen as little men in regards to medical dosage. In 1986, National Institute of Health established a policy that encouraged researchers to include women in studies.  We have quickly come a long way, but you need to remember, despite your love and treatment of your pet, they are just not mini-humans.  The medical side of the pet care industry is over $2.6 billion in North American.

Photo by Anthony de Kroon via Unsplash

This doesn’t include events like July 4th and other packed and very noisy holidays that send pets into stress overtime.  This leads to the question, can I use CBD or THC on my pet.  The answer is yes to CBD with conditions and generally no to THC.  First, always talk to your vet, and second, always find something that is made for pets.  And here is why.

Medical Marijuana and Pets

it is well know chocolate is toxic to dogs. While rarely fatal, chocolate ingestion can result in significant illness. Chocolate is toxic because it contains a chemical called theobromine, as well as caffeine. Dogs have more cannabinoid receptors in their brains, which means the effects of cannabis are more dramatic and potentially more toxic when compared to humans. Likewise, a small amount of cannabis is all it takes to cause toxicity in cats and dogs.

Cats and dogs can become intoxicated by cannabis in various ways, most commonly by accidentally eating edibles (e.g., baked goods, candies, chocolate bars, and chips containing cannabis), or cannabis directly (in any form). Dogs have more cannabinoid receptors in their brains, which means the effects of cannabis are more dramatic and potentially more toxic when compared to humans. A small amount of cannabis is all it takes to cause toxicity in cats and dog

Animals are sensitive to the presence of tetrahydrocannabinol (THC), the psychoactive compound in cannabis plant. Its dangers are prevalent. “If you ask any of our emergency room veterinarians, they would all say that the number of cannabis-intoxicated dogs has increased by leaps and bounds since legalization of medical and then recreational marijuana for humans,” UC Davis professor of vet sciences, Karl Jandrey, told the Los Angeles Times.

CBD and Pets

It’s only normal to want the best for our pet dogs and cats, and the use of cannabidiol has shown to be more than promising. In fact, CBD could very well be the treatment we’ve all been looking for to extend the lives of our pets, and add life to their years. CBD products are perfectly safe for your furry friend as long as they’re derived from the hemp variety of the cannabis plant. Products derived from the marijuana variety of cannabis, however, are not safe for animal consumption, as they typically contain high levels of THC and can thus be toxic to animals.  And yes, you can give CBD to your dog before the fireworks, if you talk to your vet and give it a few hours before to allow time for the calming effect.A website that doubles as an educational portal was launched by the Veterinary Cannabis Society (VCS) for veterinarians, as well as pet owners and cannabis businesses. This follows years of the exploding popularity of cannabidiol use for pets, as it’s shown promise in helping treat many ailments naturally from cancer and anxiety, to arthritis and old age. But despite this, there are still many questionable claims, uses, and products out there.

Starting in October 2021, Nevada became the first state in the country to pass a law that allows licensed veterinarians to recommend and administer hemp and cannabidiol products. This means that Nevada is the first state to legalize the use of cannabinoids as a veterinary treatment.

Steve Yeager, an assembly member who sponsored the bill, said that it clarified vet rules around the use of CBD. Additionally, they can also talk to pet owners about it and consult with them about its use, dosage, and even administer the medication to pets directly. “They can do all that without having to worry about being disciplined by their board, which was really the main concern behind the bill,” says Yeager. Meanwhile, in Michigan and California, vets are only allowed to consult regarding cannabis use but aren’t allowed to administer them to their pets.

With the widespread use of cannabis in more than 40 states medically, and 22 states recreationally, there still are no guidelines on the appropriate use of CBD for pets even with a flourishing market as entrepreneurs saw an opportunity to develop products made for pets.

We expect the pet cannabis industry to continue booming, with the hopes that more vets and pet owners will have the knowledge and guidance that they need in order to safely and confidently medicate their cats and dogs.  Remember, just like you wouldn’t give your dog a martini or your cat rosé, don’t get them an edible and hope for the best.

Source: https://thefreshtoast.com/cannabis/can-my-pet-use-my-medical-marijuana-or-cbd/

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Alleged Crores Pharma Scam Mastermind Arrested from Surat

Published

on

By

After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.

Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.

Fake Business Deals and Dishonoured Cheques Used in Fraud

Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.

In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”

Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.

Multiple Identities and Repeated Fraud Pattern

Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.

Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.

Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.

Multi-State Surveillance Leads to Arrest in Surat

A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.

Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.

Growing Threat of Corporate Identity Fraud

The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.

Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.

Experts Urge Stronger Due Diligence in High-Value Transactions

Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.

Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.

Continue Reading

Business

EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices

Published

on

By

A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.

Investigation Under Digital Markets Act Gains Momentum

The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.

Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.

Industry Groups Demand Swift Action

Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.

Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.

In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.

Google Denies Allegations

Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.

However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.

Potential Billion-Euro Penalties

If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.

Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.

Wider Implications for Big Tech

The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.

A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.

As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.

Continue Reading

AI & Technology

Amazon Faces Potential Criminal Trial in Italy Over €1.2 Billion Tax Evasion Allegations

Published

on

By

Milan: U.S. tech giant Amazon is facing the prospect of a major legal showdown in Italy, after prosecutors in Milan formally requested a court to move forward with criminal proceedings over alleged tax evasion totaling approximately ₹12,500 crore (€1.2 billion).

The case targets Amazon’s European division along with four senior executives, marking one of the most significant tax-related investigations involving a global e-commerce platform in Europe.

Trial Push Despite Multi-Million Euro Settlement

The move comes even after Amazon reached a financial settlement with Italian tax authorities in December, agreeing to pay around ₹5,500 crore (€527 million), including interest, to resolve part of the dispute.

Typically, such settlements lead to the closure of criminal investigations. However, Milan prosecutors have opted to proceed, signaling a tougher stance on alleged corporate tax violations.

A preliminary hearing is expected in the coming months, where a judge will decide whether to formally indict the company and its executives or dismiss the case.

Allegations of VAT Evasion Through Marketplace Sellers

At the center of the investigation are claims that Amazon’s platform enabled non-European Union sellers to avoid paying value-added tax (VAT) on goods sold to Italian consumers between 2019 and 2021.

Prosecutors allege that the company’s marketplace structure allowed thousands of foreign vendors—many reportedly based in China—to operate without fully disclosing their identities or tax obligations. This, authorities argue, led to substantial VAT losses for the Italian government.

Under Italian law, online platforms facilitating sales can be held partially liable if third-party sellers fail to comply with tax requirements, a key point in the prosecution’s case.

Italian Government Named as Affected Party

In their filing, prosecutors identified Italy’s Economy Ministry as the injured party, citing significant financial damage resulting from the alleged tax evasion.

Legal experts say the outcome of the case could have wide-ranging implications across the European Union, where VAT systems are harmonized and similar compliance rules apply to digital marketplaces.

Multiple Investigations Add to Pressure

The VAT probe is just one of several legal challenges facing Amazon in Italy. The European Public Prosecutor’s Office is reportedly examining additional tax-related issues covering more recent years.

Meanwhile, Milan authorities are pursuing separate investigations into alleged customs fraud linked to imports from China and whether Amazon maintained an undeclared “permanent establishment” in Italy—potentially exposing it to higher tax liabilities.

In a separate regulatory action, Italy’s data protection authority recently ordered an Amazon unit to stop using personal data from over 1,800 employees at a warehouse near Rome.

Amazon Denies Allegations

Amazon has consistently denied wrongdoing and indicated it will strongly contest the allegations in court if the case proceeds. The company has also warned that prolonged legal uncertainty could impact investor confidence and Italy’s appeal as a destination for international business.

Broader Impact on Europe’s Digital Economy

If the case moves to trial, it could become a landmark moment for the regulation of global e-commerce platforms in Europe. Governments across the region are increasingly scrutinizing how digital marketplaces handle tax compliance, especially in cross-border transactions.

With online retail continuing to expand, regulators are under mounting pressure to ensure that multinational platforms and third-party sellers adhere to the same tax rules as traditional businesses.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News